Target intelligence / Profile preview

GRM8 antisense RNA 1 (GRM8-AS1)

Target
GRM8-AS1
Molecular classification
Other (long non-coding RNA; antisense RNA)
01

Overview

GRM8 antisense RNA 1 (GRM8-AS1) is a long non-coding RNA gene that is transcribed in the antisense direction relative to the GRM8 gene, which encodes the metabotropic glutamate receptor 8. While the specific biological roles of GRM8-AS1 are not well characterized, antisense RNAs typically act to regulate the expression of their overlapping sense gene through mechanisms such as transcriptional interference, RNA duplex formation, and modulation of mRNA stability or translation. There are currently no direct associations of GRM8-AS1 with diseases, nor is it considered a direct target for approved drugs or therapeutic intervention[2][3]. The related protein product of GRM8 is a well-studied G protein-coupled receptor with roles in neurotransmission and disease[1][7]. GRM8-AS1 is not a receptor, enzyme, or common drug target. If the intent is to find information on "GRM8" (glutamate metabotropic receptor 8), refer to entries for the receptor itself, which fits canonical therapeutic target profiles[1][7]. The present entry refers strictly to the non-coding RNA.

Other names
GRM8-AS1GRM8 Antisense RNA 1
02

Mechanism of action

Not applicable; no drugs target GRM8-AS1

03

Biological functions

Regulation of gene expression (particularly regulation of GRM8)Transcriptional interference (general property of antisense RNAs)Epigenetic regulation (general property of antisense RNAs)
04

Disease associations

Unknown (no direct disease associations identified for GRM8-AS1; the related protein GRM8 has been implicated in cancer and neurological disorders[4][7])

Beyond the preview

Go deeper on GRM8 antisense RNA 1 (GRM8-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRM8 antisense RNA 1 (GRM8-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call